Found 8 matching trials
Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis
PHASE2The investigator, the subject, and the sponsor's project team will remain b...
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
PHASE3A randomized, double-blind, placebo-controlled phase III study evaluating t...
Location
The First Affiliated Hospital of Anhui Medical University
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
PHASE2The purpose of this study is to compare the efficacy and safety of ICP-332 ...
Location
Shanghai Dermatology Hospital
ICP-332 in Subjects With Non-segmental Vitiligo
PHASE2This a phase II/III randomized, double-blind, placebo-controlled, parallel ...
Location
The First Affiliated Hospital of Wannan Medical College
A Phase I Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Study of ICP-332 in Healthy Subjects
PHASE1This is a randomized, double-blind, placebo-controlled, parallel group, sin...
Location
Jinan Central Hospital
Phase I Study of ICP-332 in Healthy Subjects
PHASE1A multiple ascending dose phase I study of ICP-332 in healthy subjects...
Location
Pharmaron CPC Inc.
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
PHASE2Evaluate the efficacy and safety of ICP-332 in participants with Prurigo No...
Location
Cahaba Dermatology and Skin Health Center
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
PHASE2The purpose of this study is to compare the efficacy and safety of ICP-332 ...
Location
Bengbu Medical University First Affiliated Hospital